Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril for Kidney Disease Prevention in HIV-Infected Adults
NCT03201939Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisinopril in chronic kidney disease (CKD), sponsored by Vanderbilt University Medical Center. Started Apr 2021; status: terminated.
02
Drugs
lisinopril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03201939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201939.